Drug shortage
Amoxicillin Powder · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Apr 7, 2025
Key facts
| Generic name | Amoxicillin Powder, For Suspension |
|---|---|
| Proprietary name | Amoxicillin |
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Amoxicillin, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-78) |
| Dosage form | For Suspension, Powder |
| Strength | 400 mg/5 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Anti-Infective Pediatric |
| Package NDCs | 0093-4161-78 |
| First posted | Oct 28, 2022 |
| Last updated | Apr 7, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: